Streaming giant Netflix announced on Thursday a subscription fee increase of up to 17 percent, its first hike since launching the service in South Korea in 2016. The streaming platform’s standard plan will cost 13,500 won ($11.45) a month, up 12.5 percent from the previous 12,000 won, and the premium plan will go up 17.24 percent to 17,000 won from 14,500 won. The basic plan will remain unchange...

South Korea will spend 20 billion won ($16.9 million) next year to nurture local industries for materials, parts and equipment for chips, future cars, bio products and nanotechnologies, officials said Wednesday. Finance Minister Hong Nam-ki, unveiling a road map to identify and strengthen the weakest link in the country’s industrial value chain, said if all goes as planned, the country will see ...

South Korean pharmaceutical firm Yuhan said Wednesday that the company’s nonalcoholic steatohepatitis treatment candidate YH25724 will go through a phase 1 clinical trial in Europe. The test will involve some 80 healthy overweight adults to test safety, tolerability and pharmacodynamics of the NASH drug candidate. Yuhan expects that the study to be completed by June next year. With the commenc...

The South Korean government announced Tuesday it will develop hydrogen and ammonia as feedstock for thermal power generation in order to gradually phase out the use of fossil fuels. According to the Ministry of Trade, Industry and Energy, the government has launched a public-private council to lead the research, with an aim of introducing hydrogen and ammonia in the fuel mix as early as 2030. T...

The South Korean government announced Tuesday it will develop hydrogen and ammonia as feedstock for thermal power generation in order to gradually phase out the use of fossil fuels. According to the Ministry of Trade, Industry and Energy, the government has launched a public-private council to lead the research, with an aim of introducing hydrogen and ammonia in the fuel mix as early as 2030. T...

South Korean pharmaceutical giant Celltrion’s Truxima, the first biosimilar of Roche’s blockbuster cancer drug Rituxan (rituximab), has a market share close to 50 percent in major European countries, the company said Monday. According to Celltrion Healthcare, which is in charge of Celltrion’s overseas business, the combined market share of Truxima in the UK, France, Italy, Germany and Spain reac...

Hyundai Mobis, Hyundai Motor’s future mobility software and component unit, announced Sunday that the company has developed a new driver assistance system, specifically designed to help drivers navigate narrow streets and get in and out of small parking spaces. The company said the Mobis Parking System, the first of its kind in the world, is specialized for countries like South Korea and Europea...

When Google announced on Nov. 4 that it was changing its controversial in-app payment policy in South Korea to comply with a revision to the Telecommunications Business Act, dubbed the “anti-Google law,” it appeared that Korea had become the first country in the world to check the US tech behemoth’s growing control of the app ecosystem. But, less than a week after the announcement, Seoul officia...

T he Ministry of Food and Drug Safety said Wednesday it will revoke licenses of six botulinum toxin products manufactured by Hugel and Pharma Research Bio for failing to obtain due authorization. Hugel, South Korea’s leading botulinum toxin products maker, however, said it would fight the ministry’s move, saying their products, produced for overseas sales, were not subject to the regulation. U...

After Google’s move to allow a free choice of payment options for digital purchases made on its app store in South Korea, attention is turning to Apple, the other global tech giant targeted by a new law here. As of Friday, Apple remained silent on how it plans to comply with the law, which was passed by the National Assembly in August as the world’s first aimed at curbing the dominance of Google...

SK Bioscience announced Friday positive results from phase 1 and 2 clinical studies of its COVID-19 vaccine candidate GBP510, increasing the prospect of Korea’s first homegrown coronavirus vaccine debuting next year. The Korean firm said people who received the vaccine candidate had neutralizing antibodies at levels 3-6 times higher than those of people who recovered from COVID-19. No severe si...

Samsung Biologics has purchased land in Songdo, Incheon, to build a production facility for genetic medicines, the Incheon Free Economic Zone Authority said Thursday. The pharmaceutical firm has signed a deal with the authority, which oversees a plan to develop a bio cluster in Songdo, to purchase 10,000 square meters of land in the city. The site was put up for sale in June. There, Samsung Bio...

Apple Korea’s general manager Brandon Yoon will resign from his position, industry sources said Thursday. According to the sources, Yoon tendered his resignation from the position at the company on Thursday. The company refrained from offering a confirmation. Yoon has led Apple Korea since 2018. Before coming to Apple Korea, Yoon worked at Samsung Electronics. He also worked for Microsoft from ...

Samsung Group’s leader Lee Jae-yong will have to pay a 70 million won ($59,200) fine for illegal use of propofol, an anesthetic medication, judicial sources said Wednesday. The fine was finalized as both prosecutors and the defendant have not filed an appeal by Tuesday, the last day of the seven-day window to appeal the court order. The Seoul Central District Court last week ordered Lee to pay ...

GC Pharma announced Tuesday that the European Medicines Agency has granted orphan drug designation to its Hunterase ICV, a novel treatment for mucopolysaccharidosis type II, also known as the Hunter syndrome. The designation brings a variety of significant advantages under the EMA’s effort to encourage the development of drugs to treat rare diseases or conditions. GC Pharma said the company wil...